正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

🧬 Take a look inside a 3D tissue bioprinting lab! NIH postdoctoral fellow Dr. Cristina Antich Acedo demonstrates how cutting-edge bioprinting can recreate human tissue structure. By combining different cell types and biomaterials, researchers can mimic real biological environments with precision. 🔬 This technology helps accelerate the path from... show more

NIH

1,742,626 subscribers

14,475 次观看 • 1 个月前 •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

⚡🎉 We are thrilled to introduce VORTEX, an AI-powered computational framework for predicting 3D Spatial Transcriptomics (ST) using 3D tissue images and minimal 2D ST! 🧬 By combining cutting-edge 3D non-destructive tissue imaging with AI, VORTEX imputes the 3D molecular landscape of large tissue samples in a cost-effective and scalable manner. 🧠💡Our approach: By pretraining on diverse 3D morphology–2D transcriptomic pairs from heterogeneous tissue samples, and then fine-tuning on minimal 2D ST data from a volume of interest, VORTEX leverages both generic tissue-specific and sample-specific morphomolecular correlates to predict 3D ST. Congratulations to our superstar co-leads Cristina Almagro Pérez and Andrew H. Song, this was an exciting collaboration with Jonathan Liu Sizun Jiang Ali Bashashati. Preprint: Demo: Read the excellent blog from our superstar grad student Cristina Almagro Pérez: Also see our previous work on 3D Computational Pathology from Andrew H. Song published in Cell last year: Stay tuned for more to come.

⚡🎉 We are thrilled to introduce VORTEX, an AI-powered computational framework for predicting 3D Spatial Transcriptomics (ST) using 3D tissue images and minimal 2D ST! 🧬 By combining cutting-edge 3D non-destructive tissue imaging with AI, VORTEX imputes the 3D molecular landscape of large tissue samples in a cost-effective and scalable manner. 🧠💡Our approach: By pretraining on diverse 3D morphology–2D transcriptomic pairs from heterogeneous tissue samples, and then fine-tuning on minimal 2D ST data from a volume of interest, VORTEX leverages both generic tissue-specific and sample-specific morphomolecular correlates to predict 3D ST. Congratulations to our superstar co-leads Cristina Almagro Pérez and Andrew H. Song, this was an exciting collaboration with Jonathan Liu Sizun Jiang Ali Bashashati. Preprint: Demo: Read the excellent blog from our superstar grad student Cristina Almagro Pérez: Also see our previous work on 3D Computational Pathology from Andrew H. Song published in Cell last year: Stay tuned for more to come.

Faisal Mahmood

17,991 次观看 • 1 年前

Take a look inside the lab where AI helps run the experiments. 🧪 FutureHouse combines AI with robotics and biology tools to automate scientific discovery—testing new ideas faster than any human team could. Andrew White 🐦‍⬛ Sam Rodriques

Take a look inside the lab where AI helps run the experiments. 🧪 FutureHouse combines AI with robotics and biology tools to automate scientific discovery—testing new ideas faster than any human team could. Andrew White 🐦‍⬛ Sam Rodriques

Abundance Institute

21,885 次观看 • 7 个月前

.Jay Bhattacharya, MD, PhD and Dr. @NKleinstreuer talk about NIH’s shift toward human-focused research and how NIH will no longer issue NOFOs exclusively for animal models. Watch the latest episode of The Director’s Desk to hear more:

.Jay Bhattacharya, MD, PhD and Dr. @NKleinstreuer talk about NIH’s shift toward human-focused research and how NIH will no longer issue NOFOs exclusively for animal models. Watch the latest episode of The Director’s Desk to hear more:

NIH

143,611 次观看 • 1 年前

❝We all believe that ultimately the system will save lives❞ #NATO is working with researchers in Czechia🇨🇿 to develop a new technology that helps field medics take faster and more accurate decisions on the battlefield

❝We all believe that ultimately the system will save lives❞ #NATO is working with researchers in Czechia🇨🇿 to develop a new technology that helps field medics take faster and more accurate decisions on the battlefield

NATO

143,752 次观看 • 3 年前

NIH researchers are exploring how immature cells called stem cells develop into specialized cells like heart or lung cells. This research on how cells keep their DNA organized during that specialization process could help advance the development of lab grown organs for thousands of people waiting on a transplant. Watch the full video to learn more:

NIH researchers are exploring how immature cells called stem cells develop into specialized cells like heart or lung cells. This research on how cells keep their DNA organized during that specialization process could help advance the development of lab grown organs for thousands of people waiting on a transplant. Watch the full video to learn more:

NIH

19,895 次观看 • 4 个月前

📣 Introducing Learn More Faster: How to Find Your Bullseye Customer and Their Perfect Product, a new book by GV's Michael Margolis! 📚 Startups can learn how to accelerate customer discovery (for free!) on Co.Design shares more —

📣 Introducing Learn More Faster: How to Find Your Bullseye Customer and Their Perfect Product, a new book by GV's Michael Margolis! 📚 Startups can learn how to accelerate customer discovery (for free!) on Co.Design shares more —

GV

15,834 次观看 • 2 年前

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception

NVIDIA AI Developer

26,637 次观看 • 1 年前

Our popular Tommy Eagan 😆 was in the hospital with Teratoma. A Teratoma is a type of tumor made of different kinds of body tissues, because it develops from germ cells (cells that can become many tissue types). These tumors can contain unusual tissues like hair, teeth, muscle, bone, or even nerve tissue. Grey's Anatomy 🧬

Our popular Tommy Eagan 😆 was in the hospital with Teratoma. A Teratoma is a type of tumor made of different kinds of body tissues, because it develops from germ cells (cells that can become many tissue types). These tumors can contain unusual tissues like hair, teeth, muscle, bone, or even nerve tissue. Grey's Anatomy 🧬

PaPi

178,645 次观看 • 2 个月前

NEW episode! Drug development has never been more expensive, in terms of output per dollar spent. This trend, called Eroom’s law, is surprising, considering the incredible technological advances in drug discovery, from genome sequencing to engineering to microscopy. On a new episode of the Works in Progress podcast, Ben Southwood and I talk to Ruxandra Teslo 🧬 about why this has happened and what can be done about it. We discuss how: • AI isn’t a magic bullet for drug discovery. Predictive models lack the physical human data, like individual variation and rare side effects, that can only be generated by actually running real-world clinical trials. • As scientists invent more effective drugs, it becomes harder to discover new treatments that can surpass past successes. This is known as the "Better than the Beatles" problem. • Biotech companies are increasingly moving their "first-in-human" trials to Australia because its simpler regulations allow researchers to test drug safety faster and cheaper than in the US. • Clinical trials can be made more efficient with various reforms including: embracing platform trials, allowing researchers to select from independent ethics boards, expanding the funding and validation of surrogate endpoints, increasing transparency by releasing regulatory correspondence from failed companies, and much more. Timestamps: 00:00:00 Eroom’s law and the paradox of drug development 00:08:03 How clinical trials actually work 00:10:23 The power and controversy of surrogate endpoints 00:14:01 How historical patent laws influenced trial timelines 00:22:46 The Australia advantage and regulatory drag 00:29:08 Institutional review boards (IRBs) and bureaucratic drag 00:32:21 Open science and successful reforms 00:41:49 Our wishlist for clinical trial reforms, and which reforms we *don’t* like 00:53:48 Why AI isn’t a magic bullet for drug discovery

NEW episode! Drug development has never been more expensive, in terms of output per dollar spent. This trend, called Eroom’s law, is surprising, considering the incredible technological advances in drug discovery, from genome sequencing to engineering to microscopy. On a new episode of the Works in Progress podcast, Ben Southwood and I talk to Ruxandra Teslo 🧬 about why this has happened and what can be done about it. We discuss how: • AI isn’t a magic bullet for drug discovery. Predictive models lack the physical human data, like individual variation and rare side effects, that can only be generated by actually running real-world clinical trials. • As scientists invent more effective drugs, it becomes harder to discover new treatments that can surpass past successes. This is known as the "Better than the Beatles" problem. • Biotech companies are increasingly moving their "first-in-human" trials to Australia because its simpler regulations allow researchers to test drug safety faster and cheaper than in the US. • Clinical trials can be made more efficient with various reforms including: embracing platform trials, allowing researchers to select from independent ethics boards, expanding the funding and validation of surrogate endpoints, increasing transparency by releasing regulatory correspondence from failed companies, and much more. Timestamps: 00:00:00 Eroom’s law and the paradox of drug development 00:08:03 How clinical trials actually work 00:10:23 The power and controversy of surrogate endpoints 00:14:01 How historical patent laws influenced trial timelines 00:22:46 The Australia advantage and regulatory drag 00:29:08 Institutional review boards (IRBs) and bureaucratic drag 00:32:21 Open science and successful reforms 00:41:49 Our wishlist for clinical trial reforms, and which reforms we don’t like 00:53:48 Why AI isn’t a magic bullet for drug discovery

Saloni

109,256 次观看 • 2 个月前

AI is transforming drug discovery, enabling faster breakthroughs that lead to better patient outcomes. With Dell AI Factory with @NVIDIA you can simplify the adoption of cutting-edge technology needed to drive these advancements, with solutions tailored to you needs.

AI is transforming drug discovery, enabling faster breakthroughs that lead to better patient outcomes. With Dell AI Factory with @NVIDIA you can simplify the adoption of cutting-edge technology needed to drive these advancements, with solutions tailored to you needs.

Dell Technologies

5,589,846 次观看 • 2 个月前

Ranging in size from as small as a speck of pepper to the size of an apple seed, ticks can be hard to spot and remove, increasing the chance of exposure to tick-borne diseases. NIH researchers are exploring how to trigger a process found in animals, where molecules called cytokines activate the neurons that cause us to itch. This would allow humans to scratch off a tick before it can transmit disease. Watch the full video to learn more:

Ranging in size from as small as a speck of pepper to the size of an apple seed, ticks can be hard to spot and remove, increasing the chance of exposure to tick-borne diseases. NIH researchers are exploring how to trigger a process found in animals, where molecules called cytokines activate the neurons that cause us to itch. This would allow humans to scratch off a tick before it can transmit disease. Watch the full video to learn more:

NIH

11,519 次观看 • 3 个月前

“Just the idea that 2-meter-long DNA can be wrapped up in a tiny cell is just mind-boggling” – Dr. Peter Park on how NIH-supported research led to key discoveries about DNA organization’s impact on health & disease. Watch the full video:

“Just the idea that 2-meter-long DNA can be wrapped up in a tiny cell is just mind-boggling” – Dr. Peter Park on how NIH-supported research led to key discoveries about DNA organization’s impact on health & disease. Watch the full video:

NIH

17,808 次观看 • 1 年前

Larry Ellison explains how AI-powered surgical robots now surpass even the most skilled human doctors. Unlike humans, these robots have microscopic vision built into their sensors. They can see individual cells without a microscope. This allows them to cut with extreme precision removing cancer without harming healthy tissue. Their unmatched hand-eye coordination makes surgeries more accurate and less invasive.

Larry Ellison explains how AI-powered surgical robots now surpass even the most skilled human doctors. Unlike humans, these robots have microscopic vision built into their sensors. They can see individual cells without a microscope. This allows them to cut with extreme precision removing cancer without harming healthy tissue. Their unmatched hand-eye coordination makes surgeries more accurate and less invasive.

Wes Roth

257,648 次观看 • 8 个月前

.Secretary Kennedy announces the Office of Research Innovation, Validation, and Application (ORIVA) to help accelerate the use of research technologies that will reduce reliance on animal testing at NIH. "A major win for animal welfare."

.Secretary Kennedy announces the Office of Research Innovation, Validation, and Application (ORIVA) to help accelerate the use of research technologies that will reduce reliance on animal testing at NIH. "A major win for animal welfare."

Rapid Response 47

80,202 次观看 • 22 天前

Introducing Meta Locate 3D: a model for accurate object localization in 3D environments. Learn how Meta Locate 3D can help robots accurately understand their surroundings and interact more naturally with humans. You can download the model and dataset, read our research paper, and even try a demo!

Introducing Meta Locate 3D: a model for accurate object localization in 3D environments. Learn how Meta Locate 3D can help robots accurately understand their surroundings and interact more naturally with humans. You can download the model and dataset, read our research paper, and even try a demo!

AI at Meta

81,287 次观看 • 1 年前

⚡️📣👇Tremendously excited to share our new Cell article, where we develop TriPath, a method for analyzing 3D pathology samples using weakly supervised AI. Article: TriPath enables 3D computational pathology via 3D multiple instance learning allowing AI models to capture intricate morphological details from pathology volumes. Code: Blog post: Tested on two different imaging modalities, and patient cohorts from two institutions. Our superstar Andrew H. Song put in a monumental effort of leading the study, in a fantastic collaboration with Jonathan Liu at University of Washington . Interesting aspects: - Utilizing the whole tissue volume and leveraging 3D deep learning enable superior risk prediction performance compared to 2D deep learning baselines based on a few sampled tissue sections that emulate standard clinical practice. This indicates TriPath can harness additional information provided by 3D tissue morphology. - The performance is also superior to clinical baselines from a reader study that involved six expert pathologists. - The morphologically heterogeneous tissue volume could lead to opposing patient-level outcome predictions, dependent on which portion of the tissue volume is used. This concurs with current clinical literature warning that tissue sampling bias can lead to misdiagnosis. Some limitations: - While the 3D pathology cohort size is unprecedented, it is smaller than typical 2D pathology cohorts. Further large-scale studies will be required for validation. Nevertheless, we believe that this study will initiate a positive cycle, encouraging academic institutions and pharmaceutical companies to contribute large banks of human tissue blocks with paired clinical outcomes, thus speeding up advancements in 3D computational pathology. Concluding insights: We believe that 3D pathology is just around the corner - It has the huge potential to not only augment/improve the current clinical practice centered around 2D examination of human tissue, but also help reveal novel biomarkers for prognosis and therapeutic response.. Harvard Medical School Harvard Data Science Initiative Mass General Brigham Broad Institute

⚡️📣👇Tremendously excited to share our new Cell article, where we develop TriPath, a method for analyzing 3D pathology samples using weakly supervised AI. Article: TriPath enables 3D computational pathology via 3D multiple instance learning allowing AI models to capture intricate morphological details from pathology volumes. Code: Blog post: Tested on two different imaging modalities, and patient cohorts from two institutions. Our superstar Andrew H. Song put in a monumental effort of leading the study, in a fantastic collaboration with Jonathan Liu at University of Washington . Interesting aspects: - Utilizing the whole tissue volume and leveraging 3D deep learning enable superior risk prediction performance compared to 2D deep learning baselines based on a few sampled tissue sections that emulate standard clinical practice. This indicates TriPath can harness additional information provided by 3D tissue morphology. - The performance is also superior to clinical baselines from a reader study that involved six expert pathologists. - The morphologically heterogeneous tissue volume could lead to opposing patient-level outcome predictions, dependent on which portion of the tissue volume is used. This concurs with current clinical literature warning that tissue sampling bias can lead to misdiagnosis. Some limitations: - While the 3D pathology cohort size is unprecedented, it is smaller than typical 2D pathology cohorts. Further large-scale studies will be required for validation. Nevertheless, we believe that this study will initiate a positive cycle, encouraging academic institutions and pharmaceutical companies to contribute large banks of human tissue blocks with paired clinical outcomes, thus speeding up advancements in 3D computational pathology. Concluding insights: We believe that 3D pathology is just around the corner - It has the huge potential to not only augment/improve the current clinical practice centered around 2D examination of human tissue, but also help reveal novel biomarkers for prognosis and therapeutic response.. Harvard Medical School Harvard Data Science Initiative Mass General Brigham Broad Institute

Faisal Mahmood

65,520 次观看 • 2 年前

Excited to share new work from our lab and @versp1 led by Melissa Cadena! We're always thinking of ways to improve and customize organoid culture and differentiation. So we turned to 3D bioprinting to build tunable scaffolds for cortical organoids.

Excited to share new work from our lab and @versp1 led by Melissa Cadena! We're always thinking of ways to improve and customize organoid culture and differentiation. So we turned to 3D bioprinting to build tunable scaffolds for cortical organoids.

Steven Sloan

15,374 次观看 • 2 年前

How do different brain cell types connect with each other? We're mapping the brain to learn more. In this video from our #ElectronMicroscopy team, we see how complex brain cells can be. #BrainAwarenessWeek

How do different brain cell types connect with each other? We're mapping the brain to learn more. In this video from our #ElectronMicroscopy team, we see how complex brain cells can be. #BrainAwarenessWeek

allen institute

18,892 次观看 • 4 个月前

We are simplifying how NIH funding works so researchers can spend less time navigating complexity and more time on discovery. Stay informed with NIH Innovates, NIH’s new channel dedicated to research news and information for the biomedical research community.

We are simplifying how NIH funding works so researchers can spend less time navigating complexity and more time on discovery. Stay informed with NIH Innovates, NIH’s new channel dedicated to research news and information for the biomedical research community.

Jay Bhattacharya, MD, PhD

23,752 次观看 • 22 天前